Patent · US Active

Antibodies to aripiprazole and use thereof

US9494607B2 · kind B2 · utility

17Cited by

16References

23Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Eric Hryhorenko · Hilton, US
Banumathi Sankaran · Lexington, US
Thomas R. DeCory · Pittsford, US
Theresa Tubbs · Rochester, US
Linda Colt · Rochester, US
Bart M. Remmerie · Evergem, BE
Rhys Salter · Doylestown, US
Ronghui Lin · Ambler, US

Key dates

Filing date	Aug 20, 2013
Grant date	Nov 15, 2016
Priority date	—
Expiry date	Aug 20, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Disclosed is an antibody which binds to aripiprazole, which can be used to detect aripiprazole in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of aripiprazole, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.